904708
Pomalidomide-C6-PEG3-butyl iodide
≥95%
同義詞:
N-(2-(2,6-Dioxopiperidin-3-yl)-1,3-dioxoisoindolin-4-yl)-6-(2-(2-((6-iodohexyl)oxy)ethoxy)ethoxy)hexanamide, Crosslinker−E3 Ligase ligand conjugate, Pomalidomide-6-2-2-6-I, Protein degrader building block for PROTAC® research, Template for synthesis of targeted protein degrader
About This Item
推薦產品
ligand
pomalidomide
化驗
≥95%
形狀
powder or crystals
反應適用性
reactivity: sulfuryl reactive
reagent type: ligand-linker conjugate
官能基
alkyl halide
儲存溫度
2-8°C
SMILES 字串
ICCCCCCOCCOCCOCCCCCC(NC1=CC=CC2=C1C(N(C3CCC(NC3=O)=O)C2=O)=O)=O
應用
其他說明
Portal: Building PROTAC® Degraders for Targeted Protein Degradation
Modular PROTAC Design for the Degradation of Oncogenic BCR-ABL
Targeted Protein Degradation by Small Molecules
Small-Molecule PROTACS: New Approaches to Protein Degradation
Targeted Protein Degradation: from Chemical Biology to Drug Discovery
Impact of linker length on the activity of PROTACs
法律資訊
相關產品
儲存類別代碼
11 - Combustible Solids
水污染物質分類(WGK)
WGK 3
閃點(°F)
Not applicable
閃點(°C)
Not applicable
客戶也查看了
文章
Partial PROTACs are a collection of crosslinker-E3 ligand conjugates with a pendant functional group for covalent linkage to a target ligand.
Partial PROTACs are a collection of crosslinker-E3 ligand conjugates with a pendant functional group for covalent linkage to a target ligand.
Partial PROTACs are a collection of crosslinker-E3 ligand conjugates with a pendant functional group for covalent linkage to a target ligand.
Partial PROTACs are a collection of crosslinker-E3 ligand conjugates with a pendant functional group for covalent linkage to a target ligand.
相關內容
Targeted protein degradation (TPD) is an emerging drug discovery strategy that uses small-molecules, such as proteolysis-targeting chimeras (PROTACs), to eradicate targeted proteins linked to disease from cells.
我們的科學家團隊在所有研究領域都有豐富的經驗,包括生命科學、材料科學、化學合成、色譜、分析等.
聯絡技術服務